PMID: 9002097Jan 1, 1997Paper

Computer-generated recall letters for underimmunized children: how cost-effective?

The Pediatric Infectious Disease Journal
T A LieuH R Shinefield

Abstract

To evaluate the effectiveness and cost effectiveness of computer-generated recall letters to parents of children overdue for immunizations. This randomized controlled trial included children of two facilities in a regional health maintenance organization. Parents of 20-month-olds who had not yet received a measles-mumps-rubella (MMR) immunization were identified via a computerized immunization tracking system. One half were mailed personalized letters that included the recommended immunization schedule and a request to call for an appointment; the other half served as a control group. Receipt of the MMR between 20 and 24 months of age was evaluated with the computerized tracking system. A telephone survey was conducted with parents whose children had not received the MMR by 24 months. Decision analysis was used to project the theoretical outcomes and costs of a recall letter policy for other populations. Among 20-month-old children 10% had not received the MMR; 289 families were included in the analysis. Of families who were mailed letters, 54% (82 of 153) received the MMR by 24 months of age, compared with 35% (47 of 136) of those in the control group (P = 0.001). The telephone survey was completed with 110 parents of children...Continue Reading

References

Jan 1, 1990·Health Affairs·P J Cunningham, A C Monheit
Oct 1, 1994·American Journal of Public Health·T A LieuN E Adler
Apr 1, 1994·American Journal of Public Health·S H TaplinD Montano
Jan 1, 1994·American Journal of Public Health·E S KingP F Engstrom

❮ Previous
Next ❯

Citations

Mar 27, 2003·American Journal of Preventive Medicine·Arthur J DavidsonBrenda L Beatty
Mar 4, 2000·American Journal of Preventive Medicine·E F DiniJ Sigafoos
May 2, 2007·The Journal of Laryngology and Otology·M GeraghtyJ Kinsella
Dec 19, 2012·BMC Medical Informatics and Decision Making·Jennifer A PereiraUNKNOWN Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Th
Nov 20, 2002·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Matthew F DaleyAllison Kempe
Aug 31, 2001·American Journal of Public Health·S A WilcoxJ C Thalheimer
Feb 6, 2016·American Journal of Preventive Medicine·Verughese JacobUNKNOWN Community Preventive Services Task Force
May 23, 2006·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Stephanie L PhibbsArthur J Davidson
Oct 9, 2002·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Faruque AhmedVishnu-Priya Sneller
Jan 18, 2018·The Cochrane Database of Systematic Reviews·Julie C Jacobson VannPeter G Szilagyi
Jul 22, 2005·The Cochrane Database of Systematic Reviews·Julie C Jacobson Vann, Peter Szilagyi
Dec 30, 2014·Risk Analysis : an Official Publication of the Society for Risk Analysis·Kimberly M Thompson, Cassie L Odahowski
Oct 6, 2005·The Medical Journal of Australia·Sean R DownerAnnette C Da Costa
May 9, 2012·Pediatrics·Allison KempeL Miriam Dickinson
May 9, 2012·Pediatrics·Christina A SuhAllison Kempe
Aug 22, 2012·Pediatrics·Kathryn S BrighamEmily A Blood
Jan 3, 2001·Pediatrics·T G FerrisJ M Perrin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.